Managing concentrated equity allocations across Asia-Pacific, Arohi Asset Management Pte Ltd. runs long-short and long-only strategies for sovereign, institutional, and HNW clients. The firm focuses on small-to-large cap opportunities in technology, healthcare, and consumer sectors, combining fundamental research with event-driven trade execution. Capital is deployed via discretionary funds and segregated mandates, with risk controls centered on liquidity profiling and position limits. Headquartered in Singapore, it supports regional investor access and portfolio diversification.
Managing concentrated equity allocations across Asia-Pacific, Arohi Asset Management Pte Ltd. runs long-short and long-only strategies for sovereign, institutional, and HNW clients. The firm focuses on small-to-large cap opportunities in technology, healthcare, and consumer sectors, combining fundamental research with event-driven trade execution. Capital is deployed via discretionary funds and segregated mandates, with risk controls centered on liquidity profiling and position limits. Headquartered in Singapore, it supports regional investor access and portfolio diversification.
Specializes in concentrated Asia-Pacific equity allocations delivered through complementary long-short and long-only sleeves. Investment approach blends fundamental, event-driven and catalyst-focused research to identify asymmetric upside in technology, healthcare and consumer names across market caps. Capital allocation favors high-conviction positions sized by liquidity, scenario-based stress testing and strict position limits. Horizon is medium-to-long term with active trade execution to capture catalysts and manage drawdowns. Portfolio construction emphasizes diversification by theme and liquidity-aware risk budgeting for institutional and HNW mandates.
Specializes in concentrated Asia-Pacific equity allocations delivered through complementary long-short and long-only sleeves. Investment approach blends fundamental, event-driven and catalyst-focused research to identify asymmetric upside in technology, healthcare and consumer names across market caps. Capital allocation favors high-conviction positions sized by liquidity, scenario-based stress testing and strict position limits. Horizon is medium-to-long term with active trade execution to capture catalysts and manage drawdowns. Portfolio construction emphasizes diversification by theme and liquidity-aware risk budgeting for institutional and HNW mandates.
| Trades 41 | Longs Won 18/41 43% | Profit Factor 3.3 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $10.79M |
| Average Win $9.15M | Best Trade (Jun 01) $49.77M | Sharpe Ratio -21.86 |
| Average Loss -$2.17M | Worst Trade (Mar 31) -$9.64M | Z-Score -0.87 (61.34%) |
| Commissions $0 | Avg. Trade Length 11m 1w 3d | Expectancy $2.8M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.08% | 0.67% | 4.36% | 22.78% |
| Consecutive Losing Trades | 137 | 123 | 110 | 96 | 82 | 69 | 55 | 41 | 27 | 14 |